Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01366274
Other study ID # PMH1
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 31, 2011
Last updated June 3, 2011
Start date September 2007
Est. completion date December 2011

Study information

Verified date November 2010
Source The University of Queensland
Contact n/a
Is FDA regulated No
Health authority Australia: Human Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This single-blinded randomized study aims to compare two methods of manual hyperinflation (protective - moderate tidal volumes with positive end expiratory pressure) and non-protective (large tidal volume and no positive end expiratory pressure) in ventilated acute trauma patients, to investigate the effect on inflammatory markers, lung compliance, oxygenation and sputum volume.


Description:

Current evidence in mechanical ventilation supports a "protective lung strategy" that is, smaller tidal volumes and prevention of loss of positive end expiratory pressure (PEEP). There is concern that manual hyperinflation (MHI) may conflict with this strategy and cause volutrauma and atelectrauma potentially leading to biotrauma.

This single-blinded randomized study aims to compare two methods of manual hyperinflation (protective - moderate tidal volumes with positive end expiratory pressure) and non-protective (large tidal volume and no positive end expiratory pressure) in ventilated acute trauma patients, to investigate the effect on inflammatory markers, lung compliance, oxygenation and sputum volume.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Trauma patients

- Day 1 of admission to intensive care

- Mechanically ventilated

Exclusion Criteria:

- Pre-existing lung disease

- PEEP > 12.5cmH20

- Nitric oxide in circuit

- Haemodynamically unstable

- Undrained pneumothorax

- Intracranial pressure > 25mmHg

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Protective manual hyperinflation
Manual hyperinflation for 10 minutes using a Mapleson C circuit and 100% oxygen with volume set at 8mls/kg and positive end expiratory pressure in the circuit appropriate to baseline levels
Usual method of MHI
Manual hyperinflation for 10 minutes using a Mapleson C circuit and 100% oxygen with volume set at 12mls/kg and no positive end expiratory pressure in the circuit

Locations

Country Name City State
Australia Royal Brisbane & Womens Hospital Brisbane Queensland

Sponsors (2)

Lead Sponsor Collaborator
The University of Queensland Royal Brisbane and Women's Hospital

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interleukin 6 5 mls of arterial blood will be colected in an EDTA tube, centrifuged and aliquoted within 30 minutes. It will be stored at -80 degrees C and the analysis completed in batches by enzyme linked immunosorbent assay Change between Baseline and 40 minutes and 70 minutes post baseline No
Secondary Tumour necrosis factor alpha 5 mls of arterial blood will be colected in an EDTA tube, centrifuged and aliquoted within 30 minutes. It will be stored at -80 degrees C and the analysis completed in batches by enzyme linked immunosorbent assay Change from Baseline to 40 minutes and 70 minutes post baseline No
Secondary Interleukin 1-beta 5 mls of arterial blood will be colected in an EDTA tube, centrifuged and aliquoted within 30 minutes. It will be stored at -80 degrees C and the analysis completed in batches by enzyme linked immunosorbent assay Change between baseline and 40 minutes and 70 minutes post baseline No
Secondary Interleukin 8 5 mls of arterial blood will be colected in an EDTA tube, centrifuged and aliquoted within 30 minutes. It will be stored at -80 degrees C and the analysis completed in batches by enzyme linked immunosorbent assay Change between baseline and 40 minutes and 70 minutes post baseline No
Secondary PaO2/FiO2 Oxygenation ratio The ratio between the partial pressure of oxygen in arterial blood and the fraction of inspired oxygen which is delivered to the patient. Chnge between baseline and 15 minutes and 40 minutes post baseline No
Secondary Static lung compliance Static lung compliance is the change in volume for any given applied pressure. The formula is Compliance = Change in volume/change in pleural pressure.
An inspiratory hold will be dialled on the mechanical ventilator and the static lung compliance value will be recorded from the screen.
Change between Baseline and 15 minutes and 70 minutes post baseline No
Secondary Mean arterial blood pressure The mean blood pressure will be recorded from the arterial catheter in situ. This is displayed continuously on the Phillips Intellivue Monitor and will be recorded for the time of intervention the change between baseline and every minute during intervention for 10 minutes will be compared Yes
Secondary Sputum volume Sputum will be suctioned at the end of the manual hyperinflation technique by an inline suction catheter using sterile technique into a closed sample jar. This will be weighed on an Acculab Pocket Scale PP401 Immediately at end of intervention No